Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | ALPL | P05186 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23642318 | 0.86 | HSD17B10 (0.41) | HSD17B10ALPLTSHRALDH1A1 | |
| SCHEMBL17232763 | 0.77 | MB (0.30) | — | |
| SCHEMBL18237894 | 0.72 | — | — | |
| SCHEMBL19297180 | 0.72 | HSD17B10 (0.39) | HSD17B10ALPLTSHR | |
| SCHEMBL21554068 | 0.68 | SOS1 (0.44) | HSD17B10 | |
| SCHEMBL24045549 | 0.67 | HSD17B10 (0.39) | HSD17B10ALPLTSHRALDH1A1 | |
| SCHEMBL17232736 | 0.66 | SRC (0.32) | — | |
| SCHEMBL13948699 | 0.64 | HCAR2 (0.44) | HSD17B10TSHR | |
| SCHEMBL14048246 | 0.64 | HCAR2 (0.44) | HSD17B10TSHRALDH1A1 | |
| SCHEMBL19413426 | 0.64 | HSD17B10 (0.39) | HSD17B10ALPLTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9931407-B2 | Silicon based drug conjugates and methods of using same | BLINKBIO, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | BLINKBIO, INC. | 2017-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | CD44, MSN, AS3MT | HSD17B10 3435/4885ALPL 2344/4885TSHR 2393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.